NextBio, Genophen Link up to Use Genomic Data for Disease Prevention and Wellness | GenomeWeb

NEW YORK (GenomeWeb News) – NextBio and Genophen today said they are partnering to drive adoption of genomics for disease prevention and wellness.

They said the deal allows Genophen to interpret genomic sequencing data from patients through the use of NextBio's clinical platform and to combine this information with data about a patient's environmental, behavioral, and clinical factors "to create a uniquely tailored disease prevention and wellness plan for its individual member."

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.